About
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.
Current Value
$310.581 Year Return
Current Value
$310.581 Year Return
Key Details
Market Cap
$167.37B
P/E Ratio
41.29
1Y Stock Return
10.07%
1Y Revenue Growth
18.64%
Dividend Yield
3.45%
Price to Book
28.5
Strategies that include AMGN
Double maintains 15 strategies that include AMGN - Amgen, Inc.
Medium risk
$14,000
0.35%
US Top 500
The textbook passive investment vehicle is generally considered to comprise of 500 of the largest stocks traded within the US. Double's take on this exposes a client to the US stock market in a diversified way without any expense ratio.
Top Sector
Information Technology
Top Holdings
Bktd. Return
Expense Ratio
0.00%
Holdings
502
High risk
$2,200
1.15%
Tech 100
This index is closely related to the Nasdaq-100 Index, comprising major tech and growth-oriented companies. It aims to capture the tech sector's long-term growth prospects through exposure to the innovative and leading tech companies listed on the Nasdaq exchange.
Top Sector
Information Technology
Top Holdings
Bktd. Return
Expense Ratio
0.00%
Holdings
101
Medium risk
$6,600
0.76%
Value Stocks
This Strategy targets undervalued stocks in the U.S. market, emphasizing companies with solid fundamentals and potential for long-term growth. Emphasizing sectors such as healthcare, financials, industrials, and consumer goods, it seeks opportunities where market prices may not fully reflect underlying value metrics like earnings and book value.
Top Sector
Financials
Top Holdings
Bktd. Return
Expense Ratio
0.00%
Holdings
337
Medium risk
$13,000
2.82%
Health Care Sector
This Strategy focuses on healthcare companies, including pharmaceuticals, biotechnology, healthcare providers, and medical equipment firms. Offering exposure to a sector driven by demographic trends and ongoing medical advancements, it's a strategic choice for investors considering healthcare's long-term growth potential.
Top Sector
Health Care
Top Holdings
Bktd. Return
Expense Ratio
0.00%
Holdings
348
Medium risk
$2,900
0.19%
Equal Weighted US Top 500
This index provides equal-weight exposure to the top 500 companies in the US, offering a unique approach compared to traditional market-cap weighted indexes. With an aim to reduce concentration risk by allocating equal amounts to each constituent, it potentially benefits from smaller companies' outperformance.
Top Sector
Industrials
Top Holdings
Bktd. Return
Expense Ratio
0.00%
Holdings
502
Low risk
$2,800
0.16%
Low risk
$4,700
0.28%
Medium risk
$33,000
0.32%
US 1000
This strategy tracks a market-cap-weighted index of the 1000-largest US companies. It offers broad exposure to the US equity market, encompassing a diverse range of sectors and industries. By investing in this fund, you gain access to the performance of large and well-established companies within the US economy.
Top Sector
Information Technology
Top Holdings
Bktd. Return
Expense Ratio
0.00%
Holdings
1001
High risk
$1,000
1.90%
Stock's related to AMGN
The stocks that are correlated to AMGN - Amgen, Inc. are JYNT, ALE, KBH, PFE, BIIB
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| 43.92% | $189.53M | -2.42% | 0.00% | |
A ALEALLETE, Inc. | 43.60% | $3.81B | +10.18% | 4.34% |
K KBHKB Home | 42.89% | $4.15B | -16.82% | 1.71% |
P PFEPfizer Inc. | 42.26% | $143.71B | -8.59% | 6.70% |
B BIIBBiogen, Inc. | 41.26% | $20.03B | -36.30% | 0.00% |
T TECHBio-Techne Corp. | 40.60% | $9.27B | -15.53% | 0.55% |
| 39.78% | $280.46M | -29.72% | 10.78% | |
| 39.73% | $16.01B | -26.29% | 5.60% | |
| 39.69% | $2.15B | +4.30% | 2.62% | |
| 39.62% | $7.70B | -43.99% | 0.00% | |
| 39.15% | $419.18M | +35.99% | 0.00% | |
| 38.70% | $14.05B | -20.40% | 1.98% | |
Q QGENQIAGEN NV | 38.61% | $8.74B | -8.13% | 0.00% |
G GSKGSK Plc | 38.38% | $78.79B | -8.68% | 4.01% |
G GFFGriffon Corp. | 38.23% | $3.40B | -0.97% | 0.91% |
| 38.19% | $19.48B | +7.58% | 1.25% | |
| 38.16% | $22.53B | -12.77% | 0.85% | |
| 37.51% | $306.71M | +7.29% | 0.00% | |
| 37.39% | $31.08B | -29.16% | 0.00% | |
| 36.86% | $69.34B | -34.57% | 0.00% | |
ETF's related to AMGN
The ETFs that are correlated to AMGN - Amgen, Inc. are BBH, FHLC, IBB, IXJ, VHT
Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| 64.69% | $368.79M | 0.35% | |
| 56.93% | $2.69B | 0.084% | |
| 56.90% | $5.92B | 0.45% | |
| 56.89% | $3.93B | 0.41% | |
| 56.59% | $16.42B | 0.09% | |
| 56.32% | $38.07B | 0.09% | |
| 56.21% | $3.18B | 0.39% | |
| 55.96% | $790.11M | 0.4% | |
| 54.98% | $69.83B | 0.06% | |
| 52.85% | $960.13M | 0.62% | |
| 51.46% | $233.11M | 0.58% | |
| 49.06% | $1.08B | 0.56% | |
| 48.85% | $9.08B | 0.6% | |
| 48.09% | $1.21B | 0.36% | |
| 48.06% | $290.25M | 0% | |
| 47.28% | $5.31B | 0.45% | |
| 47.24% | $19.88B | 0.35% | |
| 46.88% | $664.88M | 0.36% | |
| 46.80% | $3.36B | 0.2% | |
| 46.75% | $11.64B | 0.35% | |
News
Yahoo
GILD vs. AMGN: Which Stock Is the Better Value Option?
MarketWatch
Dow falls nearly 150 points on losses for Johnson & Johnson, Merck shares
SeekingAlpha
Dogs Of The Dow Chase April's 'Safer' Buy
Yahoo
The overseers of the Dow Jones Industrial Average might regret adding Nvidia to the index. Since it joined the Dow industrials on Nov. 7, Nvidia stock is down nearly 30%. Nvidia stock is on track for its worst month since September 2022, when it lost nearly 20%, according to Dow Jones Market Data.
Yahoo
Trump's upcoming tariffs has the potential to bring biopharma manufacturing to the US, which could impact companies with overseas production. Jefferies managing director Michael Yee joins Market Domination Overtime to discuss how tariffs could impact the biotech sector, emphasizing Vertex (VRTX), Amgen (AMGN), and Gilead (GILD) as some of his top large-cap picks in the sector. To watch more expert insights and analysis on the latest market action, check out more Market Domination Overtime here.
Yahoo
Amgen (AMGN) concluded the recent trading session at $311.55, signifying a +1.5% move from its prior day's close.
Disclaimer
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.
0% Expense Ratios with TLH
We offer over 50 indexes with zero expense ratios.
Registration will take about 10 seconds